Abdul‐Quddus Mohammed

ORCID: 0000-0003-0475-1760
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Imaging and Diagnostics
  • Cardiovascular Function and Risk Factors
  • Acute Myocardial Infarction Research
  • Cardiovascular Disease and Adiposity
  • Coronary Interventions and Diagnostics
  • Atrial Fibrillation Management and Outcomes
  • Advanced MRI Techniques and Applications
  • Heart Failure Treatment and Management
  • Viral Infections and Immunology Research
  • Cardiovascular Health and Disease Prevention
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Adipokines, Inflammation, and Metabolic Diseases
  • Case Reports on Hematomas
  • Inflammasome and immune disorders
  • Gout, Hyperuricemia, Uric Acid
  • Cardiovascular, Neuropeptides, and Oxidative Stress Research
  • Heme Oxygenase-1 and Carbon Monoxide
  • Dietary Effects on Health
  • Cardiac Health and Mental Health
  • Lipoproteins and Cardiovascular Health
  • Neonatal Health and Biochemistry
  • Biomarkers in Disease Mechanisms
  • Thyroid Cancer Diagnosis and Treatment
  • Thyroid Disorders and Treatments
  • Blood properties and coagulation

Shanghai Tenth People's Hospital
2018-2025

Tongji University
2018-2025

Abstract Background Recent studies highlighted that stress hyperglycemia ratio (SHR) is a potential predictor for future risk in heart failure (HF) patients. However, its implications specifically HF with preserved ejection fraction (HFpEF) are not yet fully elucidated. We aimed to investigate the association between SHR and long-term clinical outcomes HFpEF Methods patients enrolled 2015 2023, were followed (mean 41 months) composite outcome of all-cause, cardiovascular mortality,...

10.1186/s12933-024-02157-7 article EN cc-by Cardiovascular Diabetology 2024-02-13

Stress hyperglycemia ratio (SHR) is a novel biomarker of true acute condition and associated with worse prognosis in patients myocardial infarction (MI). However, the effects SHR setting MI non-obstructive coronary arteries (MINOCA) have not been investigated. This study aimed to explore association between long-term clinical outcomes among MINOCA patients.A total 410 were included final analysis this study. The divided into three groups based on tertiles: [SHR1 group (SHR ≤ 0.73), (n =...

10.1186/s12933-023-01742-6 article EN cc-by Cardiovascular Diabetology 2023-01-16

The Atherogenic Index of Plasma (AIP) is a newly identified biomarker associated with lipid metabolism, demonstrating significant prognostic capabilities in individuals diagnosed cardiovascular disease. However, its impact within the context chronic coronary syndromes (CCS) remains unexplored. Thus, present investigation sought to examine potential association between AIP levels and long-term clinical outcomes patients CCS.A total 404 CCS who underwent angiography were included this study....

10.1186/s12933-023-01989-z article EN cc-by Cardiovascular Diabetology 2023-09-21

Abstract Background Coronary microvascular dysfunction (CMD) is common and associated with unfavorable cardiovascular events in patients diabetes mellitus (DM). angiography-derived index of microcirculatory resistance (caIMR) a recently developed wire- hyperemic agent-free method to assess CMD. We aimed investigate the prognostic impact CMD assessed by caIMR on clinical outcomes DM chronic coronary syndrome (CCS). Methods CCS who underwent angiography between June 2015 May 2018 were...

10.1186/s12933-022-01653-y article EN cc-by Cardiovascular Diabetology 2022-10-29

Abstract Background Coronary microvascular dysfunction (CMD) is a strong determinant of prognosis in patients with chronic coronary syndrome (CCS). The triglyceride-glucose index (TyG index), an alternative method to evaluate insulin resistance, positively correlated the incidence and adverse outcomes cardiovascular diseases. However, relationship between TyG presence CMD CCS has not been investigated. Therefore, we aimed association clinical among patients. Methods who underwent angiography...

10.1186/s12933-023-01846-z article EN cc-by Cardiovascular Diabetology 2023-05-13

Abstract Background Ischemia and no obstructive coronary artery disease (INOCA) is increasingly recognized associated with poor outcomes. The triglyceride-glucose (TyG) index a reliable alternative measure of insulin resistance significantly linked to cardiovascular adverse prognosis. We investigated the association between TyG myocardial ischemia prognosis in INOCA patients. Methods patients who underwent both angiography perfusion imaging (MPI) were included consecutively. All participants...

10.1186/s12933-024-02230-1 article EN cc-by Cardiovascular Diabetology 2024-05-31

Abstract: Myocardial infarction with nonobstructive coronary arteries (MINOCA) has been and remained a puzzling clinical entity. The role of secondary prevention therapy in patients MINOCA remains unclear. This study aimed to evaluate the associations between medications outcomes MINOCA. A total 259 were consecutively enrolled. Basic information medication assessed. We defined major adverse cardiovascular events as primary end point angina rehospitalization point. Logistic regression models...

10.1097/fjc.0000000000000918 article EN Journal of Cardiovascular Pharmacology 2020-12-01

White blood cell count to mean platelet volume ratio (WMR) and neutrophil-to-platelet (NPR) have been demonstrated as prognostic inflammatory biomarkers of the acute coronary syndrome. We aimed evaluate value WMR NPR among myocardial infarction with nonobstructive arteries (MINOCA) patients.A total 274 MINOCA patients were enrolled. Baseline clinical data, panel, biochemical parameters evaluated. The classified according medians NPR. primary endpoint present study was major adverse...

10.1155/2022/5642406 article EN cc-by Mediators of Inflammation 2022-08-16

Objective Coronary microvascular dysfunction (CMD) may associate with adverse cardiovascular events in obese patients. angiography-derived index of microcirculatory resistance (caIMR) is proposed as a less-invasive and pressure-wire-free to assess CMD. We aimed investigate the impact coronary function assessed by caIMR patients overweight chronic syndrome (CCS). Methods CCS who underwent angiography between 2015 2018 were included. Overweight was defined BMI≥24.0kg/m². Impaired caIMR≥25U....

10.3389/fendo.2022.922264 article EN cc-by Frontiers in Endocrinology 2022-08-10

Ischemic pain with no-obstructive coronary artery (INOCA) is clinically significant and defined by nonobstructive stenosis <50%. Coronary microvascular dysfunction (CMD) a relevant cause associated adverse outcomes.Investigated the effect of no-stenosis (0% stenosis) non-obstructive < 50%) on prognostic impact CMD in INOCA.A retrospective study assessed function 151 INOCA patients who underwent invasive angiography angiography-derived index microcirculation-resistance (caIMR). CZT-SPECT was...

10.1002/clc.23962 article EN cc-by Clinical Cardiology 2022-12-25

The fibrosis-4 index (FIB-4) is a non-invasive tool to assess fibrosis risk in chronic liver disease. We aimed explore the relationship between FIB-4 and long-term major adverse cardiovascular events (MACE) HCM patients.

10.1002/ehf2.14977 article EN cc-by-nc ESC Heart Failure 2024-07-24

We examined differences in clinical profiles, predictors, and outcomes among patients with myocardial infarction (MI) nonobstructive coronary arteries (MINOCAs) by sex. Data of 259 (132 males 127 females) MINOCA were consecutively collected. The primary end point was major adverse cardiovascular events (MACE), including death, nonfatal MI, stroke, heart failure, angina rehospitalization. Female likely to be older than male higher non-ST elevation rate. Total cholesterol, high-density...

10.1177/00033197211028428 article EN Angiology 2021-07-07
Coming Soon ...